Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001213900-25-064242·LakeShore Biopharma Co., Ltd.
Schedule 13D ownership disclosure
LAKESHORE BIOPHARMA CO LTD
Ordinary Shares, par value $0.0002 per share · CUSIP: G9845F208
Event date: 2025-07-11
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Fung Ching WongReported CIK 0002011156
Shares: 9,836,010.00 · Class: 23.9%
- Apex Prospect Limited
Shares: 9,836,010.00 · Class: 23.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-064242
- Form type
- SCHEDULE 13D/A
- Filer
- LakeShore Biopharma Co., Ltd.
- CIK
- CIK 1946399
- Filed
- Jul 15, 2025
- Reporting period
- Jul 11, 2025
- Description
- Schedule 13D beneficial ownership